Use of Repris Needle in Bladder Injection

Uro-1 Medical

Status: Unknown

Conditions: Overactive Bladder Syndrome

Treatments: Device: Repris Needle

Study type: Interventional

Funder types: Industry

Identifiers

NCT04982120

Repris Botox Study

Details and patient eligibility

About

Treatment of overactive bladder (OAB) has been treated successfully by the injection of Botox. The Repris injection needle has a deflection that may assist in injection difficult to reach with standard straight needles. This study will assess the success, safety and patient tolerance of this new injection needle.

Full description

This is a prospective, multicenter, single arm study of the Repris injection needle to administer Botox to the bladder wall in patients with an overactive bladder. Following advancement of a cystoscope to the patient's bladder, the Repris needle will be advanced to the area of interest and into the bladder wall in order to administer the recommended volume of Botox. After injection, the needle will be removed and the procedure will be concluded. The patient will be asked to rank her tolerance of the procedure and level of discomfort using a standardized pain scale before being released. Five days after the procedure the patient will be contacted by telephone to determine whether any adverse events had occurred since release.

Enrollment: 40 estimated patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult (18 years of age or older)
• Able to undergo routine cystoscopy
• Willing to provide verbal assessment of her condition within 5 days after the procedure

Exclusion criteria

• History of urethral strictures
• Presence of a suprapubic catheter or tube due to urethral trauma
• history of interstitial cystitis
• currently being treated for a urinary tract infection (UTI)
• gross hematuria present
• Known allergy or sensitivity to any component of the medication or solution to be injected during the study
• is pregnant, lactating, or with child-bearing potential unable or unwilling to use a reliable form of contraception while participating in the study
• cannot empty her bladder on her own and is routinely catheterizing the urethra
• unable to read, understand, and/or provide a ranking of pain level during the procedure,
• unable or unwilling to provide consent

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

40 participants in 1 patient group

Repris Needle

Experimental group

Description:

Reprise sheath and needle

Treatment:

Device: Repris Needle